![]() |
|
|
Vol. 299, Issue 1, 220-226, October 2001
Department of Pharmacology, Tulane University School of Medicine,
New Orleans, Louisiana
Cocaine abuse has been reported to result in QT prolongation in humans;
however, the mechanisms underlying this effect are still poorly
understood. In this study we compared the direct effects of cocaine and
its major metabolites in human embryonic kidney 293 cells stably
transfected with human ether-a-go-go-related gene
(HERG). Cocaine blocked HERG-encoded potassium channels with an
IC50 of 4.4 ± 1.1 µM (22°C). Cocaethylene (a
metabolite formed in the presence of ethanol) had a significantly lower
IC50 of 1.2 ± 1.1 µM (P < 0.0001), and cocaine's primary pyrolysis metabolite methylecgonidine
blocked HERG with a higher IC50 of 171.7 ± 1.2 µM.
In contrast, 1 mM ecgonine methylester or benzoylecgonine produced only
a minimal block (21 ± 4 and 15 ± 8%, respectively). Blockade of HERG by cocaine, cocaethylene, and methylecgonidine increased significantly over the voltage range where HERG activates, but became constant at voltages where HERG activation was maximal, indicating that all three drugs block open channels, but by a mechanism
that is not highly sensitive to voltage per se. Cocaine and
cocaethylene also significantly slowed the time course of deactivation
at
60 mV, an effect consistent with open channel block. We conclude
that cocaethylene is slightly more potent than cocaine as a blocker of
HERG, whereas methylecgonidine has much lower potency, and both
benzoylecgonine and ecgonine methyl ester are essentially inactive at
clinically relevant concentrations.
This article has been cited by other articles:
![]() |
D Taylor, D Parish, L Thompson, and M Cavaliere Cocaine induced prolongation of the QT interval Emerg. Med. J., March 1, 2004; 21(2): 252 - 253. [Full Text] |
||||
![]() |
M. E. O'Leary, M. Digregorio, and M. Chahine Closing and Inactivation Potentiate the Cocaethylene Inhibition of Cardiac Sodium Channels by Distinct Mechanisms Mol. Pharmacol., December 1, 2003; 64(6): 1575 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Katchman, K. A. McGroary, M. J. Kilborn, C. A. Kornick, P. L. Manfredi, R. L. Woosley, and S. N. Ebert Influence of Opioid Agonists on Cardiac Human Ether-a-go-go-related Gene K+ Currents J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 688 - 694. [Abstract] [Full Text] [PDF] |
||||